Further evidence of validity of the Modified Melbourne Assessment for neurologically impaired children aged 2 to 4 years
Further evidence of validity of the Modified Melbourne Assessment for neurologically impaired children aged 2 to 4 years
复制标题
DOI：
10.1111/j.1469-8749.2012.04252.x
复制
发表时间：
2012-05-01
影响因子：
3.8
通讯作者：
Carey, Leeanne
中科院分区：
文献类型：
--
作者：
Randall, Melinda;Imms, Christine;Carey, Leeanne
目的本文报告了一项研究的第二阶段，以扩大墨尔本评估用于儿童神经功能缺损2至4岁。目的是确定（1）儿童在改良墨尔本评估（MMA）和上肢技能质量测试（QUEST）上的分数是否显示出中度到高度的正相关，（2）儿童在两种工具上的任务和时间需求行为相当，（3）MMA分数可以区分轻度、中度和重度上肢损伤儿童。方法对30例2 ~ 4岁神经功能缺损患儿进行观察性研究。24名儿童患有痉挛（20名儿童患有单侧痉挛，4名儿童患有双侧痉挛），2名儿童患有手足徐动症，2名儿童患有共济失调，2名儿童患有张力减退。结果儿童MMA和QUEST的得分之间存在高度正相关（q= 0.90; p= 0.001）。theMMA的临床使用与QUEST相当。MMA评分能够区分由临床医生评定的儿童上肢损伤水平（F2，27= 67.76，p= 0.001）。解释这些研究结果表明，MMA可以是临床上有用的儿童年龄为2.5岁，并具有有效的使用与年龄较大的儿童的优势。该工具的评分还可以为治疗师提供上肢损伤水平的定量指标。
Aim This paper reports the second phase of a study to extend the Melbourne Assessment for use with children with neurological impairment aged 2 to 4 years. The aim was to establish if (1) childrens scores on the Modified Melbourne Assessment (MMA) and the Quality of Upper Extremity Skills Test (QUEST) showed a moderate to high, positive relation, (2) children had comparable behaviours for task and time demands on both tools, and (3) scores on the MMA could discriminate between children with mild, moderate, and severe levels of upper limb impairment. METHOD An observational study of 30 children (19 males, 11 females) with neurological impairment aged 2 to 4 years. Twenty-four children had spasticity (20 with a unilateral and four with a bilateral impairment) and two children presented with athetosis, two with ataxia, and two with hypotonia. RESULTS A high, positive relation was found between children's scores on the MMA and the QUEST (q= 0.90; p= 0.001). The clinical use of theMMA was comparable to the QUEST. MMA scores were able to discriminate between children's levels of upper limb impairment as determined by clinicians' ratings (F2,27= 67.76, p= 0.001). INTERPRETATION These findings suggest the MMA can be clinically useful for children as young as 2.5 years and has the advantage of being valid for use with older children. Scores from the tool can also provide therapists with a quantitativemeans of consistently reporting level of upper limb impairment.